RBKS
Basic information
Region (hg38): 2:27781379-27890681
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RBKS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 0 | 0 |
Variants in RBKS
This is a list of pathogenic ClinVar variants found in the RBKS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-27781660-C-G | not specified | Uncertain significance (Oct 29, 2021) | ||
2-27781739-T-G | not specified | Uncertain significance (Oct 05, 2023) | ||
2-27781763-G-A | not specified | Uncertain significance (Aug 16, 2021) | ||
2-27827722-C-T | not specified | Uncertain significance (Jul 19, 2022) | ||
2-27832762-T-C | not specified | Uncertain significance (Apr 18, 2023) | ||
2-27843079-G-A | not specified | Uncertain significance (Mar 14, 2023) | ||
2-27843169-C-A | not specified | Uncertain significance (Nov 17, 2022) | ||
2-27847050-T-C | not specified | Uncertain significance (May 03, 2023) | ||
2-27847060-T-C | not specified | Uncertain significance (Oct 26, 2021) | ||
2-27847066-C-A | not specified | Uncertain significance (Jun 22, 2023) | ||
2-27848037-T-G | not specified | Uncertain significance (Jan 19, 2024) | ||
2-27848069-T-G | not specified | Uncertain significance (Feb 23, 2023) | ||
2-27848078-C-T | not specified | Uncertain significance (Apr 10, 2023) | ||
2-27858560-C-T | not specified | Uncertain significance (May 30, 2023) | ||
2-27858561-G-A | not specified | Uncertain significance (Dec 20, 2021) | ||
2-27858572-C-G | Likely benign (Jul 01, 2024) | |||
2-27890333-C-T | not specified | Uncertain significance (May 14, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RBKS | protein_coding | protein_coding | ENST00000302188 | 8 | 109735 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.16e-9 | 0.123 | 123635 | 17 | 2096 | 125748 | 0.00844 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.252 | 161 | 170 | 0.946 | 0.00000816 | 2071 |
Missense in Polyphen | 58 | 63.176 | 0.91807 | 755 | ||
Synonymous | 0.811 | 56 | 64.3 | 0.871 | 0.00000326 | 649 |
Loss of Function | 0.114 | 13 | 13.5 | 0.966 | 5.65e-7 | 180 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00396 | 0.00395 |
Ashkenazi Jewish | 0.00965 | 0.00937 |
East Asian | 0.0148 | 0.0138 |
Finnish | 0.00850 | 0.00826 |
European (Non-Finnish) | 0.0107 | 0.0104 |
Middle Eastern | 0.0148 | 0.0138 |
South Asian | 0.00894 | 0.00883 |
Other | 0.00879 | 0.00834 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the phosphorylation of ribose at O-5 in a reaction requiring ATP and magnesium. The resulting D-ribose-5- phosphate can then be used either for sythesis of nucleotides, histidine, and tryptophan, or as a component of the pentose phosphate pathway. {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|PubMed:17585908}.;
- Pathway
- Pentose phosphate pathway - Homo sapiens (human);Pentose Phosphate Pathway;Glucose-6-phosphate dehydrogenase deficiency;Ribose-5-phosphate isomerase deficiency;Transaldolase deficiency;Pentose phosphate pathway (hexose monophosphate shunt);Metabolism of carbohydrates;Metabolism;Pentose phosphate cycle
(Consensus)
Intolerance Scores
- loftool
- 0.824
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.61
Haploinsufficiency Scores
- pHI
- 0.107
- hipred
- N
- hipred_score
- 0.310
- ghis
- 0.412
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.528
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rbks
- Phenotype
Gene ontology
- Biological process
- pentose-phosphate shunt;D-ribose catabolic process;carbohydrate phosphorylation
- Cellular component
- nucleus;cytosol
- Molecular function
- ribokinase activity;protein binding;ATP binding;metal ion binding